Scarica l'app Stockscreener
36.20
0.22%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
9 Health Care Stocks Whale Activity In Today’s Session - Benzinga
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
How Roivant Sciences Ltd. (ROIV) Affects Rotational Strategy Timing - Stock Traders Daily
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Roivant Sciences Ltd (ROIV) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46 - Moomoo
Roivant Sciences (ROIV) Is Up 7.2% After Narrower Net Loss Despite Lower Quarterly Revenue - webull.com
Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings And 15% Upside Potential - directorstalkinterviews.com
Is Roivant Sciences’ (ROIV) Cost Discipline Offsetting Slower Revenue Enough to Refresh Its Story? - Yahoo Finance
Is Roivant Sciences (ROIV) Overvalued On First Quarter Results? - Yahoo Finance
Bank of America Corp DE Has $87.64 Million Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences: The Balance Sheet Has Become A Strategic Weapon - Seeking Alpha
Sei Investments Co. Acquires 33,508 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Rally Leans On Cash As Losses Persist - Sahm
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Guggenheim Issues Positive Forecast for Roivant Sciences (NASDAQ:ROIV) Stock Price - MarketBeat
Roivant Sciences Ltd (ROIV) Stock News Today - TradingKey
Roivant Sciences Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
Roivant Sciences Q1 Earnings Call Highlights - MarketBeat
Assenagon Asset Management S.A. Acquires 1,286,464 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
TD Cowen raises Roivant Sciences stock price target to $50 on execution - Investing.com South Africa
Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside - TradingView
Roivant Sciences earnings beat by $0.04, revenue fell short of estimates - Investing.com
Roivant Sciences Releases Q1 2026 Financial Results - AlphaStreet
Earnings call transcript: Roivant posts Q1 2026 EPS beat, revenue miss as shares slip - Investing.com
Roivant Sciences shares rise despite revenue miss - Investing.com
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Roivant Sciences Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
ROIV: Strong cash reserves and major settlement boost, with key product launch on track for September - TradingView
Roivant Sciences' Fiscal Q1 Net Loss Narrows, Revenue Declines - marketscreener.com
Roivant Sciences Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
ROIV: Secured $950M from Moderna, advanced pivotal trials, and prepared for a key product launch - TradingView
Roivant Sciences shares rise despite revenue miss By Investing.com - Investing.com Australia
Roivant Sciences Ltd. 2026: Revenue $1.44M, EPS ($0.26) — 10-Q Summary - TradingView
Roivant Sciences (NASDAQ: ROIV) details $771.6M Moderna settlement windfall - Stock Titan
Earnings Flash (ROIV) Roivant Sciences Ltd. Reports Q1 Revenue $1.4M, vs. FactSet Est of $2.1M - marketscreener.com
Roivant reports Q1 loss, $3.9B cash and $290.6M net loss for quarter - TradingView
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update - marketscreener.com
Roivant earnings in focus as mosliciguat trial data looms By Investing.com - Investing.com Nigeria
Roivant earnings in focus as mosliciguat trial data looms - Investing.com
Arrowstreet Capital Limited Partnership Grows Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Purchased by California State Teachers Retirement System - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 14.74% Potential Upside - directorstalkinterviews.com
Hsbc Holdings PLC Sells 31,577 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
(ROIV) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Seven Fleet Capital Management LP Purchases New Shares in Roivant Sciences Ltd. $ROIV - MarketBeat
Janus Henderson Group PLC Purchases 177,339 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. Revenue Breakdown – NASDAQ:ROIV - TradingView
Roivant Sciences (ROIV) Expected to Post Quarterly Earnings on Thursday - MarketBeat
Form 4 Roivant Sciences Ltd. For: 29 July By Investing.com - Investing.com Nigeria
Form DEF 14A Roivant Sciences Ltd. For: 29 July By Investing.com - Investing.com UK
Roivant Sciences(ROIV.US) Officer Sells US$6.99 Million in Common Stock - Moomoo
Roivant Sciences Ltd. $ROIV Shares Sold by Rubric Capital Management LP - MarketBeat
Roivant Sciences Ltd (ROIV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roivant Sciences (ROIV) affiliate files to sell 200,000 common shares after option exercise - Stock Titan
Roivant Sciences Ltd. Revenue Breakdown – SWB:87S - TradingView
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - marketscreener.com
Roivant Sciences Ltd (ROIV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Roivant Sciences Ltd (ROIV) Income Statement - TradingKey
ROIV|Roivant Sciences Ltd|Price:34.710|Chg%:-0.300 - TradingKey
TradingKey - TradingKey
0.07%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):